Archive

A rat study in Bioelectromagnetics examined GSM-modulated 3.5 GHz RF-EMF exposure (2 h/day for 30 days) and reported adverse changes in male reproductive hormones, oxidative stress markers, and testicular histology. The authors also tested Coenzyme Q10 (CoQ10) and found it partially ameliorated some RF-associated…

This RF Safe commentary argues that if HHS and FDA pursue a “reset” on cellphone radiation policy, they should fund mechanistic, predictive biology rather than relying on literature summaries or general safety reassurances. It cites the NTP rat bioassays and a WHO-commissioned animal cancer systematic review…

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing…

RF Safe argues that “no effect” findings in some RF exposure studies should be interpreted as meaningful negative controls rather than as evidence that RF has no biological effects. The post presents RF Safe’s “S4–Mito–Spin” framework, claiming certain skin cell types (fibroblasts and keratinocytes) are predicted to…

RF Safe argues that many “anti-radiation” phone cases use misleading marketing (e.g., fabric-swatch tests, vague “FCC tested” claims) and that some designs may cause phones to increase transmit power if they interfere with antennas. The article provides a checklist of red flags (magnets/metal plates, detachable…

This rat study examined acute (1-week) and chronic (10-week) exposure to 2100 MHz radiofrequency radiation (3G UMTS-like) and assessed auditory mismatch negativity (MMN) alongside biochemical and histological brain measures. The abstract reports that acute exposure was associated with reduced MMN-related…

RF Safe argues that a potential MrBeast-branded mobile service (“Beast Mobile”) could drive high adoption among children and therefore raises ethical concerns about children’s exposure to radiofrequency (RF) emissions from always-on, body-worn devices. The post claims the scientific and legal context has shifted and…

RF Safe argues that common marketing claims for anti-radiation phone cases (e.g., “99% shielding”) are misleading because they often rely on controlled lab fabric tests that do not reflect real-world phone use. The post claims factors like shield orientation, phone transmit-power increases under obstruction,…

RF Safe promotes QuantaCase (also marketed as TruthCase) as an “anti-radiation” phone case designed to deflect RF energy away from the user while maintaining phone performance. The article argues that non-thermal biological effects can occur below current exposure guidelines and cites multiple reviews and reports to…

RF Safe promotes its TruthCase™ (also called QuantaCase®) as an EMF-focused phone case positioned less as a “miracle shield” and more as a habit-forming tool paired with consumer education and advocacy for regulatory reform. The article argues many “anti-radiation” cases are misleading or may increase exposure due to…

RF Safe promotes an education-first, zero-paid-ad marketing approach for its EMF safety products, positioning itself against what it describes as a market full of overhyped or misleading “anti-radiation” gadgets. The article highlights RF Safe’s resources (e.g., a large study library and SAR tools) and argues its…

RF Safe recaps a Truth Expedition podcast episode featuring RF Safe founder John Coates discussing alleged biological risks from EMF exposure and arguing that current regulations lag behind modern science. The piece links EMFs to developmental and health concerns (including neural-tube defects and autism) via Coates’…

RF Safe argues that animal evidence for RF-related carcinogenicity is now strong and should not be dismissed, citing the NTP (2018) and Ramazzini (2018) lifetime rodent studies as showing statistically significant increases in the same rare tumor types (heart schwannomas and brain gliomas). The post further claims…

This RF Safe article argues that the “strongest” RF-EMF literature supports concern about cancer-related findings, emphasizing non-monotonic dose–response patterns in the U.S. National Toxicology Program (NTP) rat study and citing additional analyses and animal studies. It reports that FDA evaluations have downplayed…

This RF Safe article argues that U.S. radiofrequency (RF) exposure policy is outdated, emphasizing that FCC limits adopted in 1996 are based on preventing tissue heating and do not address alleged non-thermal biological effects. It claims responsibility for protecting public health from electronic product radiation…